NDC 53002-1801
Desvenlafaxine 50 mg tablet, extended release
On the label: RPK Pharmaceuticals, Inc.. It's repackaged: RPK Pharmaceuticals, Inc. rebottles it from Actavis Pharma, Inc.'s NDC 0591-3659.
Where the pills inside were made
This label doesn't name the factory that makes the drug. Companies don't have to print it on the label. The maker's name is often on the stock bottle your pharmacy used; you can ask the pharmacist. See the plants Actavis Pharma, Inc. names for other drugs.
Repackaging site
- RPK Pharmaceuticals, Inc., Union City, California, United States · repackages it and relabels it
Recalls
- Mar 15, 2021 · Class II · Cardinal Health Inc.
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Lots: 1399650A
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Desvenlafaxine: every company that makes it
- Form
- tablet, extended release
- Strength
- 50 mg
- Approval
- ANDA ANDA204065
- On the market since
- Mar 1, 2017
- Package NDCs
53002-1801-3- Official label
- DailyMed (National Library of Medicine), updated Jan 31, 2023
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?